BofA Securities Downgrades Esperion Therapeutics (ESPR) to Underperform
Tweet Send to a Friend
(Updated - June 20, 2024 8:12 AM EDT)
BofA Securities analyst Jason Zemanski downgraded Esperion Therapeutics (NASDAQ: ESPR) from ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
BofA Securities analyst Jason Zemanski downgraded Esperion Therapeutics (NASDAQ: ESPR) from ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
